Ashwin Raguraman
Founding Partner @ Bharat Innovation Fund
Mumbai, India
Ashwin Raguraman is a seed investor at Bharat Innovation Fund in Mumbai focused on Health Care and Machine Learning. Ashwin Raguraman - Member, Board of Directors @ iKen Solutions
- Total investments:
- 12
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Ashwin Raguraman invests in
Stages Ashwin Raguraman invests in
Countries Ashwin Raguraman invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 4 (33%)
- Machine Learning 2 (17%)
- SaaS 1 (8%)
- EdTech 1 (8%)
- Medical 1 (8%)
Stage
- Seed 4 (33%)
- Series A 3 (25%)
- Series B 3 (25%)
- Venture - Series Unknown 1 (8%)
Country
- India 7 (58%)
- United States 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Zumutor is a leading Immuno-Oncology company in the space of targeted NK cell therapeutics. They have two proprietary Antibody Engineering Platforms to develop novel immunotherapies that target innate immunity and regulate the tumor microenvironment. | $7.3M / Series B / Jun 13, 2026 | ||
| Virohan is an EdTech company that offers healthcare vocational training to students to build a career in the healthcare industry. Virohan uses technology and talent to fix this socio-economic problem so that industry demand and skilled workforce are in perfect equilibrium.Virohan is re-engineering vocational training by aggregating the highlyfragmented vocational training industry and standardizing their operations from mobilization, training to placements. Virohan's tech stack's plug-and-play installation at training centers assures demand-driven training is provided to students in an affordable, accessible, and standardized manner to ensure youth achieve progressive livelihoods, the industry receives a trained workforce, and training centers have higher revenues and profitability.Virohan’s target audience is marginalized, low-income youth in the age group of 16-24, with about 50% of them being females. Virohan provides courses in Healthcare covering Allied Health, Corporate Training, and Refresher training for hospital employees in an omnichannel training model.The courses offered emphasize on development of core technical skills, language abilities, and life skills in the student through gamified blended learning delivered by its facilitators in classrooms. All programs include long internships at hospitals for hands-on practice of the skills acquired. It is a fee-based model and in order to encourage young people to join, financial linkages are provided with easy installment-based payback options after a job is secured by the young person.Virohan's tech stack predicts job demand, mobilizes youth as per that demand, trains them, and connects them with jobs. In essence, this increases viable penetration, lowering operational costs and improving efficiency across operations (mobilization, financing, training, certification, placement) through standardization. | $7.3M / Series B / Dec 19, 2025 | ||
| Portl is a digital platform that combines advanced sensors & proprietary fitness technologies with AI to create Holistic Health solutions for consumers and athletes. | $3M / Seed / May 23, 2024 | ||
| ClaimBuddy acts as one-stop solutions for Health Insurance Claim assistance for Patients and Hospitals. ClaimBuddy are building an ecosystem to ensure Hassle-free insurance claims by leveraging technology, and a set of simple yet powerful processes and operations. | $5M / Series A / Apr 12, 2024 | ||
| Entropik is the global leader in Emotion AI, powering a Unified Human Insights Platform. Our platform turns human emotions into business intelligence so brands can understand and connect with customers in more meaningful ways.Business Impact: Our unified platform delivers insights in days, not weeks. Teams launch faster, optimize campaigns withconfidence, and turn research from a cost center into a competitive advantage. | $25M / Series B / Feb 08, 2023 | ||
| Virohan is an EdTech company that offers healthcare vocational training to students to build a career in the healthcare industry. Virohan uses technology and talent to fix this socio-economic problem so that industry demand and skilled workforce are in perfect equilibrium.Virohan is re-engineering vocational training by aggregating the highlyfragmented vocational training industry and standardizing their operations from mobilization, training to placements. Virohan's tech stack's plug-and-play installation at training centers assures demand-driven training is provided to students in an affordable, accessible, and standardized manner to ensure youth achieve progressive livelihoods, the industry receives a trained workforce, and training centers have higher revenues and profitability.Virohan’s target audience is marginalized, low-income youth in the age group of 16-24, with about 50% of them being females. Virohan provides courses in Healthcare covering Allied Health, Corporate Training, and Refresher training for hospital employees in an omnichannel training model.The courses offered emphasize on development of core technical skills, language abilities, and life skills in the student through gamified blended learning delivered by its facilitators in classrooms. All programs include long internships at hospitals for hands-on practice of the skills acquired. It is a fee-based model and in order to encourage young people to join, financial linkages are provided with easy installment-based payback options after a job is secured by the young person.Virohan's tech stack predicts job demand, mobilizes youth as per that demand, trains them, and connects them with jobs. In essence, this increases viable penetration, lowering operational costs and improving efficiency across operations (mobilization, financing, training, certification, placement) through standardization. | $6.8M / Series B / Dec 08, 2022 | ||
| Human Edge is a longevity science company with the vision of democratising the healthspan of the workforce across the globe. | $1.5M / Seed / Aug 29, 2022 | ||
| The company aims to use its patented technology to provide cataract treatment at one-tenth the present cost, and with better outcomes. | Venture - Series Unknown / Jul 14, 2022 | ||
| Entropik is the global leader in Emotion AI, powering a Unified Human Insights Platform. Our platform turns human emotions into business intelligence so brands can understand and connect with customers in more meaningful ways.Business Impact: Our unified platform delivers insights in days, not weeks. Teams launch faster, optimize campaigns withconfidence, and turn research from a cost center into a competitive advantage. | $8M / Series A / Sep 02, 2020 | ||
| Zumutor is a leading Immuno-Oncology company in the space of targeted NK cell therapeutics. They have two proprietary Antibody Engineering Platforms to develop novel immunotherapies that target innate immunity and regulate the tumor microenvironment. | $4M / Series A / Nov 28, 2019 | ||
| See all 12 investments → | |||
Co-Investors
About Bharat Innovation Fund
They believe India, that is Bharat, and its transformational entrepreneurs are producing globally competitive and disruptive solutions for some of the toughest challenges. Their ventures can be game-changers not only in the Indian context - but emerge as dominant leaders globally.Through their early-stage capital, unparalleled networks, strategicinsights and operational hand-holding, they can significantly de-risk the process of conversion of these ideas into companies of consequence.
Bharat Innovation Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Ashwin Raguraman
Founding Partner
|
|||
Kunal Upadhyay
Managing Partner
|
|||
|
Saras Agarwal
Principal
|
|||
Shyam Menon
Partner & Co-founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Ashwin Raguraman invest in?
Ashwin Raguraman invests primarily in Health Care, Machine Learning and SaaS startups, most often at Seed and Series A stage. Most of the 12 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ashwin Raguraman?
Public channels for Ashwin Raguraman include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ashwin Raguraman last invest?
The most recent investment recorded for Ashwin Raguraman closed in Jun 2026. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
